Direct-to-Patient Clinical Trials

Direct-to-Patient Clinical Trials

Suvoda is proud to sponsor and present at CBI's 2nd Annual Direct-to-Patient Clinical Trials. This conference provides a unique opportunity to collaborate with industry pioneers through a mix of real-world examples, interactive discussions and engaging panels to navigate this emerging landscape and successfully enable direct-to-patient trials.

Suvoda will be co-presenting with Bellerophon Therapeutics, discussing how the right IRT system can help simplify and streamline the complexity of Direct-to-Patient clinical trials.

Case Study: Managing a Successful Direct-to-Patient Clinical Trial Using IRT
Thursday, August 8, 2019
2:40 pm EST

Lisa Killi, Director of Clinical Supplies Management, Bellerophon

Shivanni Sukha, Technical Consultant, Services, Suvoda

Conference Insights and Takeaways:

• Assess key factors to determine when a virtual, hybrid or traditional model is the best fit for a clinical trial
• Identify unexpected challenges to recruitment and
  conduct in a siteless trial
• Evaluate, implement and maintain new technology
• Break down current CTTI and FDA guidance documents on decentralized trials
• Restructure traditional supply chains to adapt to
  siteless models
• Partner with home healthcare providers to enable
  virtual and hybrid trials

Register Here
8-9 August 2019
Philadelphia, PA